Cost-effectiveness analysis of extended thromboprophylaxis with rivaroxaban versus no prophylaxis in high-risk patients after hospitalisation for COVID-19: an economic modelling st... by Caroline Cândida Carvalho de Oliveira, Leandro Barile Agati, Camilla Moreira Ribeiro, Valéria Cristina Resende Aguiar, Roberto Augusto Caffaro, Marisa da Silva Santos, Ricardo Ribeiro Alves Fernandes, Carlos Alberto da Silva Magliano, Alfonso Tafur, Alex C. Spyropoulos, Renato Delascio Lopes, Jawed Fareed, Eduardo Ramacciotti

Connect to this object online.